AVALO THERAPEUTICS, INC. Other Commitment, to be Paid, Year Two
AVALO THERAPEUTICS, INC. (AVTX) had Other Commitment, to be Paid, Year Two of $3.00 million as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Commitment and Contingencies › Other Commitments › Other Commitment, Fiscal Year Maturity › Other Commitment, to be Paid, Year Two and Three
us-gaap:OtherCommitmentDueInSecondYear · last filed 2019-05-09
- 2019-03-31: Other Commitment, to be Paid, Year Two $3.00M.
- 2018-12-31: Other Commitment, to be Paid, Year Two $3.00M.
- 2018-09-30: Other Commitment, to be Paid, Year Two $3.00M.
| Period end | Other Commitment, to be Paid, Year Two |
|---|---|
| 2019-03-31 | $3.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.00M 10-K · filed 2019-03-18 |
| 2018-09-30 | $3.00M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |